首页> 外国专利> SYSTEMS AND METHODS FOR SPECTRAL IMAGING CHARACTERIZATION OF MACROPHAGES FOR USE IN PERSONALIZATION OF TARGETED THERAPIES TO PREVENT FIBROSIS DEVELOPMENT IN PATIENTS WITH CHRONIC LIVER DISEASE

SYSTEMS AND METHODS FOR SPECTRAL IMAGING CHARACTERIZATION OF MACROPHAGES FOR USE IN PERSONALIZATION OF TARGETED THERAPIES TO PREVENT FIBROSIS DEVELOPMENT IN PATIENTS WITH CHRONIC LIVER DISEASE

机译:用于巨噬细胞的光谱成像表征的系统和方法,用于靶向疗法的个性化以防止慢性肝病患者纤维化发育

摘要

The present invention includes a method of macrophage phenotype profiling for the assessment, determination, and stratification of risk of development of fibrosis and/or cirrhosis within the liver, and treatment thereof, comprising the steps of: (a) obtaining a liver biopsy sample from a subject; (b) using fluorescently labeled antibodies to analyze the sample, by laboratory assay, for marker identification and expression comparison of one or more macrophage profiling markers relative to the level of expression of a macrophage profiling marker in at least one control or standard sample, and (c) using spectral analysis to correlate the fluorescent signal generated by the macrophage profiling marker/antibody complex to the risk of developing fibrosis and/or cirrhosis, and treating with anti-viral agents or changes in diet, weight loss, or reduction of fat consumption.
机译:本发明包括用于评估,测定和分层的巨噬细胞表型分析的方法,其肝脏纤维化和/或肝硬化的风险,及其处理,包括以下步骤:(a)从中获得肝活检样本 课程; (b)使用荧光标记的抗体通过实验室测定来分析样品,用于标记鉴定和一种或多种巨噬细胞分析标志物相对于至少一种对照或标准样品中的巨噬细胞分析标记的表达水平的表达比较,以及 (c)使用光谱分析,将巨噬细胞分析标志物/抗体复合物产生的荧光信号与发育纤维化和/或肝硬化的风险相关,并用抗病毒剂治疗或饮食变化,减肥或减少脂肪 消耗。

著录项

  • 公开/公告号US2021293814A1

    专利类型

  • 公开/公告日2021-09-23

    原文格式PDF

  • 申请/专利权人 HEATHER STEVENSON;OMAR SALDARRIAGA;

    申请/专利号US202017079236

  • 发明设计人 HEATHER STEVENSON;OMAR SALDARRIAGA;

    申请日2020-10-23

  • 分类号G01N33/569;G01N33/58;G01N21/64;

  • 国家 US

  • 入库时间 2022-08-24 21:12:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号